Treatment Options for Hypertension (HTN)
The treatment of hypertension should follow a stepwise approach beginning with lifestyle modifications for all patients, followed by pharmacological therapy based on blood pressure severity, with specific medication choices determined by patient characteristics and comorbidities. 1
Diagnosis and Assessment
Before initiating treatment, confirm hypertension diagnosis:
- Use validated automated upper arm cuff device with appropriate cuff size
- Measure BP in both arms at first visit; use arm with higher BP if consistent difference
- Confirm elevated office readings (≥130/85 mmHg) with home BP monitoring (≥135/85 mmHg) or 24-hour ambulatory BP monitoring (≥130/80 mmHg)
Basic evaluation should include:
- Urine test for blood and protein
- Blood electrolytes and creatinine
- Blood glucose
- Lipid profile
- 12-lead ECG
Lifestyle Modifications
Lifestyle modifications are first-line treatment for all hypertensive patients and should include:
Diet modifications:
- Salt reduction: Limit added salt and processed foods
- DASH diet: Rich in whole grains, fruits, vegetables, and low-fat dairy
- Increase potassium intake through foods like avocados, nuts, legumes
- Moderate caffeine consumption
Physical activity:
- Regular aerobic exercise (at least 150 minutes/week)
- Dynamic activities like brisk walking preferred over isometric exercises
Weight management:
- Achieve and maintain healthy body weight
- Target BMI appropriate for ethnicity or waist-to-height ratio <0.5
Alcohol moderation:
- Men: ≤2 standard drinks/day (maximum 14/week)
- Women: ≤1.5 standard drinks/day (maximum 9/week)
- Avoid binge drinking
Smoking cessation
Stress reduction and mindfulness practices
These lifestyle interventions can reduce systolic BP by 5-10 mmHg collectively and enhance the effectiveness of medication 1, 2.
Pharmacological Treatment
When to Initiate Drug Therapy:
- BP ≥160/100 mmHg (Grade 2 hypertension): Start drug treatment immediately along with lifestyle modifications
- BP 140-159/90-99 mmHg (Grade 1 hypertension):
- Start drugs immediately in high-risk patients (CVD, CKD, diabetes, target organ damage, or age 50-80 years)
- For low-risk patients: Try lifestyle modifications for 3-6 months first; if BP remains elevated, add medication 1
Medication Selection Algorithm:
For Non-Black Patients:
- Start with low-dose ACE inhibitor (e.g., lisinopril) or ARB (e.g., losartan)
- Increase to full dose if needed
- Add thiazide/thiazide-like diuretic
- Add calcium channel blocker (CCB)
- If BP still uncontrolled, add spironolactone (or if contraindicated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker)
For Black Patients:
- Start with low-dose ARB + dihydropyridine CCB or CCB + thiazide-like diuretic
- Increase to full dose
- Add diuretic or ACE inhibitor/ARB (whichever wasn't used initially)
- If BP still uncontrolled, add spironolactone (or alternatives as above) 1
Special Populations:
Diabetes:
- Target BP <130/80 mmHg
- ACE inhibitors or ARBs preferred, especially with albuminuria
- Monitor kidney function and potassium when using ACE inhibitors, ARBs, or MRAs 1
Chronic Kidney Disease:
- ACE inhibitors or ARBs preferred first-line
- May continue these medications even as eGFR declines to <30 mL/min/1.73m² 1
Coronary Artery Disease:
- ACE inhibitors or ARBs recommended as first-line therapy 1
Pregnancy/Women of Childbearing Potential:
- ACE inhibitors, ARBs, MRAs, direct renin inhibitors, and neprilysin inhibitors are contraindicated in pregnancy
- Avoid in sexually active women of childbearing potential not using reliable contraception 1
Monitoring and Follow-up
- Target BP: <130/80 mmHg for most adults
- For elderly patients, individualize targets based on frailty
- Aim to achieve target within 3 months
- Monitor for medication side effects:
- Check serum creatinine and potassium 7-14 days after starting or changing doses of ACE inhibitors, ARBs, or MRAs
- Monitor for hypokalemia with diuretics
Common Pitfalls to Avoid
Underestimating lifestyle modifications: These can be as effective as single-drug therapy in some patients and should be continued even when medications are needed 3
Ignoring seasonal BP variations: BP tends to be higher in cold weather and lower in warm weather (average 5/3 mmHg systolic/diastolic difference). Consider this when evaluating treatment effectiveness 1
Not accounting for racial differences in medication response: Black patients generally respond better to CCBs and diuretics than to ACE inhibitors or ARBs as monotherapy 4, 5
Inadequate medication adherence assessment: Poor adherence is a major cause of uncontrolled hypertension, affecting 10-80% of patients 1
Failing to use combination therapy when needed: Most patients with hypertension will require multiple medications to achieve target BP 6
By following this comprehensive approach to hypertension management, clinicians can significantly reduce patients' risk of cardiovascular events, stroke, and mortality.